Movement Alert｜Medline Inc Falls 5.29% in Regular Trading, FDA Violation Warning and Securities Fraud Probe Continue to Weigh on Shares

Market Focus06-12

On June 12, Medline Inc declined 5.29% in regular trading, trading at $35.185/share, with turnover of $55.21 million.

On the news front, the U.S. Food and Drug Administration issued a warning letter to Medline on May 28, citing serious violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals at the company's Illinois facility. This marks the second FDA warning letter issued to the company within a two-month span. Medline is required to respond within 15 business days detailing corrective actions taken, or it may face regulatory penalties including suspension of export certificate issuance.

Compounding regulatory pressure, the company is also facing a securities fraud investigation. The overlap of multiple regulatory risks has continued to weigh on the stock price, with shares remaining under sustained selling pressure as investors assess the potential operational and legal consequences of these developments.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1163403914?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-12 21:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1163403914","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Medline Inc Falls 5.29% in Regular Trading, FDA Violation Warning and Securities Fraud Probe Continue to Weigh on Shares","media":"Market Focus","content":"<p><p>On June 12, Medline Inc declined 5.29% in regular trading, trading at $35.185/share, with turnover of $55.21 million.</p><p>On the news front, the U.S. Food and Drug Administration issued a warning letter to Medline on May 28, citing serious violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals at the company's Illinois facility. This marks the second FDA warning letter issued to the company within a two-month span. Medline is required to respond within 15 business days detailing corrective actions taken, or it may face regulatory penalties including suspension of export certificate issuance.</p><p>Compounding regulatory pressure, the company is also facing a securities fraud investigation. The overlap of multiple regulatory risks has continued to weigh on the stock price, with shares remaining under sustained selling pressure as investors assess the potential operational and legal consequences of these developments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Medline Inc Falls 5.29% in Regular Trading, FDA Violation Warning and Securities Fraud Probe Continue to Weigh on Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Medline Inc Falls 5.29% in Regular Trading, FDA Violation Warning and Securities Fraud Probe Continue to Weigh on Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-12 21:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 12, Medline Inc declined 5.29% in regular trading, trading at $35.185/share, with turnover of $55.21 million.</p><p>On the news front, the U.S. Food and Drug Administration issued a warning letter to Medline on May 28, citing serious violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals at the company's Illinois facility. This marks the second FDA warning letter issued to the company within a two-month span. Medline is required to respond within 15 business days detailing corrective actions taken, or it may face regulatory penalties including suspension of export certificate issuance.</p><p>Compounding regulatory pressure, the company is also facing a securities fraud investigation. The overlap of multiple regulatory risks has continued to weigh on the stock price, with shares remaining under sustained selling pressure as investors assess the potential operational and legal consequences of these developments.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MDLN","symbol_name":"Medline Inc","start_time":0,"source_url":"","article_id":"1163403914","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163403914","pubTimestamp":1781272635,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 12, Medline Inc declined 5.29% in regular trading, trading at $35.185/share, with turnover of $55.21 million.On the news front, the U.S. Food and Drug Administration issued a warning letter...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MDLN":"Medline Inc"},"translate_title":"动向提示|Medline Inc常规交易下跌5.29%FDA违规警告和证券欺诈调查继续打压股价","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDLN":1},"content_text":"On June 12, Medline Inc declined 5.29% in regular trading, trading at $35.185/share, with turnover of $55.21 million.On the news front, the U.S. Food and Drug Administration issued a warning letter to Medline on May 28, citing serious violations of Current Good Manufacturing Practice regulations for finished pharmaceuticals at the company's Illinois facility. This marks the second FDA warning letter issued to the company within a two-month span. Medline is required to respond within 15 business days detailing corrective actions taken, or it may face regulatory penalties including suspension of export certificate issuance.Compounding regulatory pressure, the company is also facing a securities fraud investigation. The overlap of multiple regulatory risks has continued to weigh on the stock price, with shares remaining under sustained selling pressure as investors assess the potential operational and legal consequences of these developments.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-2","news_tag":"policyRegulatory","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163403914","isCrawlerRequest":true}